Osaic Holdings’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History
Bought
Maintained
Sold
Other funds holding LKFT
Osaic Holdings's LKFT Position: Q3 2026 in Review
Osaic Holdings reduced its Lakefront Biotherapeutics American Depositary Shares (LKFT) stake by 44% in Q3 2026, selling an estimated $6.7K and leaving 299 shares worth $8.85K. The position accounts for ﹤0.01% of the portfolio, ranked #6696.
Osaic Holdings first reported a position in LKFT in Q1 2020 and has held it in 27 quarters since. The position peaked at $718K in Q1 2020. 95 funds tracked by Wall St. Rank hold LKFT as of Q3 2026.
- Osaic Holdings held 299 shares of Lakefront Biotherapeutics American Depositary Shares worth $8.85K as of Q3 2026.
- Osaic Holdings sold 234 Lakefront Biotherapeutics American Depositary Shares shares in Q3 2026, an estimated $6.7K.
- Lakefront Biotherapeutics American Depositary Shares made up ﹤0.01% of Osaic Holdings's portfolio in Q3 2026, its #6696 holding.
- Osaic Holdings first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q1 2020 and has held it in 27 quarters since.
- Osaic Holdings's Lakefront Biotherapeutics American Depositary Shares position peaked at $718K in Q1 2020.
- 95 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q3 2026.
Based on Osaic Holdings's 13F filing for Q3 2026, filed 12 Nov 2026.